LDS/Medical Tests/Estriol, Unconjugated, Serum

Estriol, Unconjugated, Serum

Estriol is one of the three main estrogens produced during pregnancy. It is made in part by the fetus and in part by the placenta. It is then transported to the maternal liver, where it is conjugated to form estriol sulfates and glucuronides, the conjugated forms. As a result, “free” estriol, the unconjugated form, accounts for about nine percent of the total estriol in circulation; the estriol sulfates, which are relatively long-lived, account for roughly half.

Urinary estriol consists entirely of conjugated forms because only free estriol enters the maternal circulation while only the conjugated forms are excreted. Normally, as the fetus develops, estriol production increases, resulting in a nearly three-fold rise in circulating estriol levels during the final trimester, and a corresponding increase in urinary levels. There is typically a surge at about the 36th week and this is useful in determining fetal age . According to the literature, free and total estriol concentrations reach approximately 15 and 250 ng/mL at term, while urinary output climbs to approximately 45 mg/day. After 40 weeks, estriol levels subside, declining by roughly 12 percent a week. Persistently low or rapidly declining estriol levels suggest fetal distress. However, because estriol concentrations are subject to diurnal and episodic variation, it is common practice to refer serum measurements to a baseline, defined for the patient as either the average or the highest of their most recent estriol results. A drop of 40% or more relative to this baseline is likely to be significant. Because there is wide variation between patients and becuase of diurnal variation, serial measurements done at the same time each day are recommended.

Estriol, along with alpha-fetoprotein (AFP maternal), human chorionic gonadotropin (hCG), and inhibin-A (an ovarian and placental hormone) tests, are used to assess the risk of having a fetus with certain abnormalities, such as Down syndrome, open spina bifida, and trisomy 18.

  • Used as a marker for prenatal screening for chromosomal abnormalities (triple and quad screen)
  • As an aid in diagnosis of pregnancy complications (failing pregnancy)
  • As an aid in diagnosis of polycystic ovary syndrome
  • In conjuction with other estrogens (estrogen fractions) for diagnosis of hormonal imbalance
  • Assessment of preterm labor risk

Increased in:

  • Pregnancy with normal fetal development
  • Increases with gestational age
  • Pending labor (approximately 4 weeks prior) associated with sudden increase
  • Fetal congenital adrenal hyperplasia, some forms

Decreased in:

  • Failed pregnancy
  • Down syndrome
  • Congenital heart disease
  • Major malformations of the fetus CNS, not involving the anterior pituitary
  • Major neural tube defects
  • Smith-Lemli-Opitz syndrome
  • X-linked ichthyosis
  • Contiguous gene syndrome
  • Aromatase deficiency
  • Primary or secondary fetal adrenal insufficiency (including maternal corticosteroid therapy)
Category

ng/dL nmol/L
Males & Non-pregnant females <2.0 <6.9
Pregnancy
(Weeks of gestation)
22 2.6–8.0 9.0–27.8
26 2.5–13.5 8.7–46.8
30 3.5–19.0 12.1–65.9
34 5.3–18.3 18.4–63.5
35 5.2–26.4 18.0–91.6
36 8.2–28.1 28.4–97.5
37 8.0–30.1 27.8–104.4
38 8.6–38.0 29.8–131.9
39 7.2–34.3 25.0–119.0
40 9.6–28.9 33.3–100.3
Chemiluminescent Immunoassay (CLIA).

Serum (SST) or Amniotic Fluid.

Saliva can be used as an alternative sample.
Specify weeks of gestation if pregnant.

Stability

  • Ambient: 3-5 days
  • Refrigerated: 5-7 days
  • Frozen: 30 days
Alphafetoprotein, Dimeric Inhibin A, hCG, PAPP-A, Chromosomal Analysis, if indicated.
1-3 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • Ginekol Pol. 2006 Jul;77(7):559-65. [PMID: 17076208]
  • J Clin Endocrinol Metab. 1979 Oct;49(4):588-93. [PMID: 479349]
  • Br J Obstet Gynaecol. 1988 Apr;95(4):334-41. [PMID: 2454652]
  • Curr Opin Obstet Gynecol. 1991 Apr;3(2):259-65 [PMID: 1717021]
  • Alan Wu. Tietz Clinical Guide to Laboratory Tests, Fourth Edition. Saunders; 4 edition (June 13, 2006). ISBN-10: 0721679757